Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Tegafur/gimeracil/oteracil
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Generic Teysuno 15mg/4.35mg/11.8mg capsules
0801030ADAAAAAA
|
Tegafur/gimeracil/oteracil | Tegafur/gimeracil/oteracil | Malignant Disease and Immunosuppression | No data available |
|
Generic Teysuno 20mg/5.8mg/15.8mg capsules
0801030ADAAABAB
|
Tegafur/gimeracil/oteracil | Tegafur/gimeracil/oteracil | Malignant Disease and Immunosuppression | No data available |
|
Teysuno 15mg/4.35mg/11.8mg capsules
0801030ADBBAAAA
|
Teysuno | Tegafur/gimeracil/oteracil | Malignant Disease and Immunosuppression | No data available |
|
Teysuno 20mg/5.8mg/15.8mg capsules
0801030ADBBABAB
|
Teysuno | Tegafur/gimeracil/oteracil | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.